doxazosinum 4 mg ut doxazosini mesilas, polyethyleni oxidum, E 321, cellulosum microcristallinum, povidonum K 29-32, int-rac-alpha-tocopherolum, silica colloidalis anhydrica, natrii stearylis fumaras corresp. natrium 0.1 mg, Überzug: acidi methacrylici et ethylis acrylatis polymerisatum 1:1, silica colloidalis hydrica, macrogolum 1450, E 171, pro compresso obducto.
Packungsbestandteile
Coated tablets
Active Agent
Dose
Doxazosine
4 mg
BAG: Active Agent
Dose
Doxazosine
4 mg
Inactive agents
Dose
additional_information
Acidi Methacrylici
Überzug
Cellulosum Microcristallinum
E 171
color.
E 321
Ethylis Acrylatis Polymerisatum
Int-Rac-Alpha-Tocopherolum
Macrogol
1450
Natrii Stearylis Fumaras
Polyethyleni Oxidum
Povidonum K
29-32
Pro Compresso Obducto
Silica Colloidalis Anhydrica
Silica Colloidalis Hydrica
Source
Data was imported : 04.05.2023
Swissmedic Registration :
Sequence :
Product name :
Registration owner: :
Product group :
Index Therapeuticus (BSV) :
Medication Code :
Date of registration :
Valid until :
Package number :
Show package size :
Commercial Form/Unit :
Swissmedic categorie. :
Active Agents :
Composition :
